Product Description: Glecirasib (KRAS G12C inhibitor 36) is a potent inhibitor of KRAS G12C. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. Glecirasib has the potential for the research of KRAS G12C-mediated cancer (extracted from patent WO2021121367A1, compound 1-2)[1].
Applications: Cancer-Kinase/protease
Formula: C31H26ClF4N7O2
References: [1]Amin LI, et al. Kras mutant protein inhibitors. Patent WO2021121367A1.